期刊文献+

雷帕霉素修饰人工晶状体植入兔眼后表面黏附细胞的实验研究 被引量:2

Experimental study on adhesion cells at surface of rapamycin modified intraocular lens after implantation in rabbit
下载PDF
导出
摘要 目的将雷帕霉素修饰人工晶状体(intraocular lens,IOLs)植入兔眼内,观察IOLs表面黏附细胞的状况,评价雷帕霉素修饰IOLs的生物相容性。方法将雷帕霉素与体积分数1%高分子多聚乳酸/多聚羟基乙酸混悬液通过静电喷涂沉积设备喷涂于IOLs光学区的外周(直径范围在4mm以外区域),制备出雷帕霉素修饰的IOLs。兔眼行透明晶状体超声乳化吸出,植入不同的IOLs并分为3组:A组(雷帕霉素修饰IOLs组,RAPA组)、B组(单纯涂层组,高分子多聚乳酸/多聚羟基乙酸组)、C组(空白对照组,普通PMMAI OLs组),每组各10只。术后3个月将兔处死,摘出眼球,取出IOLs并固定于多聚甲醛溶液中,HE染色后,对IOLs黏附的细胞情况进行分析。结果涂层雷帕霉素药物颗粒细小,均匀分布于IOLs表面。低倍镜下观察,A组IOLs表面细胞分布稀疏,B组和C组细胞密集,且细胞分布均匀;A组IOLs表面的细胞平均数量为26.56±6.10,B组为83.60±13.38,C组为79.33±9.46。经SPSS 13.0统计学软件检验,A组与B组、C组相比差异有显著统计学意义(P=0.000),而B组和C组表面的细胞数量差异无统计学意义(P>0.05)。高倍镜下观察IOLs表面细胞种类,主要有小圆细胞、纤维样细胞、巨噬细胞、异物巨细胞、上皮样细胞。A组中小圆细胞所占比例为53.3%,B组为45.0%,C组为37.8%。A组中巨噬细胞所占比例为20.0%,B组为15.0%,C组为22.6%。结论高分子可降解材料联合雷帕霉素修饰的IOLs具有良好的生物相容性。 Objective To evaluate the biocompatibility of intraocular lens (IOLs) modified by rapamycin through implanting into rabbits eyes and observe the adhesion cells on the surface of IOLs.Methods The suspension of rapamycin and 1% poly lactic-coglycolic acid(PLGA) were used as sprayed coating at the periphery of IOLs (out of the diameter of 4 mm) by static spray-coating instruments to made rapamycin modified IOLs.After transparent lens were removed by phacoemulsification,different IOLs were implanted into rabbits eyes and divided into 3 groups:Group A (RAPA group),IOLs modified by rapamycin;Group B(PLGA group),IOLs sprayed only by PLGA;Group C(control group),normal PMMA IOLs without any treatment,10 rabbits in each group.After all rabbits were ethically killed,IOLs were fixed in formaldehyde solution after taken out.The cells on the surface of IOLs were analyzed by light microscope after HE staining.Results Sprayed coating of rapamycin were with small particles and equally distributed on IOLs.Under low power microscope,the cell distribution of group A was sparse on the surface of IOLs,while was intensive and equally distributed in group B and C;The cell number on surface of IOLs were 26.56±6.10,83.60±13.38 and 79.33±9.46 in group A,B and C,respectively.There were statistically significant differences between group A and B or C(P=0.000).No significant difference of cell number was found between group B and C(P〉0.05) by LSD-t test of SPSS 13.0.Under high power microscope,the varieties of cells on IOLs were mainly small round cells,fibroblast-like cells,macrophage,foreign-body giant cells and epithelioid cells.The proportion of small round cells in A,B,C groups were 53.3%,45.0%,37.8%,respectively;Macrophage were 20.0%,15.0%,22.6%,respectively.Conclusion The IOLs modified by the compound of high molecule material PLGA and rapamycin shows good biocompatibility.
出处 《眼科新进展》 CAS 北大核心 2009年第3期178-182,共5页 Recent Advances in Ophthalmology
基金 哈尔滨医科大学附属第一医院基金资助(编号:2007088)~~
关键词 雷帕霉素 表面修饰人工晶状体 生物相容性 黏附细胞 rapamycin modified intraocular lens biocompatibility adhesion cells rabbit
  • 相关文献

参考文献15

  • 1Vargas LG, Izak AM, Apple DJ, Werner L, Pandey SK, Trivedi RH. Implantation of a single-piece, hydrophilic, acrylic, minuspower foldable posterior chamber intraocular lens in a rabbit model:clinicopathologic study of posterior capsule opacification[ J]. J Cataract Refract Surg 2003 ;29 ( 8 ) : 1613-1620.
  • 2El-Osta AA,Spalton DJ,Marshall J. In vitro model for the study of human posterior capsule opacification[ J]. J Cataract Refract Surg 2003 ;29 ( 8 ) : 1593-1600.
  • 3杨晓芳,奚廷斐.生物材料生物相容性评价研究进展[J].生物医学工程学杂志,2001,18(1):123-128. 被引量:108
  • 4Mamalis N. Intraocular lens biocompatibility[J].J Cataract Refract Surg 2002 ;28 ( 1 ) : 1-2.
  • 5袁佳琴,孙慧敏,徐延山,郭红玉,王桂琴,顾汉卿,祁明信,黄秀榕.氟-肝素表面修饰人工晶状体的实验研究[J].眼科新进展,2003,23(3):153-156. 被引量:18
  • 6王桂琴,彭秀军,顾汉卿.表面修饰硅凝胶人工晶状体植入兔眼的生物相容性[J].国际眼科杂志,2006,6(1):54-56. 被引量:7
  • 7Stepkowski SM, Chen H, Daloze P, Kahan BD. Rapamycin, a potent immunosuppressive drug for vascularized heart, kidney, and small bowel transplantation in the rat [ J ]. Transplantation 1991 ;51 ( 1 ) :22-26.
  • 8Granger DK, Cromwell JW, Chen SC, Goswitz J J, Morrow DT, Beierle FA, et al. Prolongation of renal allograft survival in a large animal model by oral rapamycin monotherapy[J].Transplantation 1995 ;59 ( 2 ) : 183-186.
  • 9DiJoseph JF, Fluhler E ,Armstrong J, Shaft M, Sehgal SN. Therapeutic blood levels of sirolimus ( rapamycin ) in the allografted rat[ J]. Transplantation 1996 ;62 ( 8 ) : 1109-1112.
  • 10Kreis H, Cisterne JM, Land W, Wramner L, Squifflet JP, Abramowicz D, et al. Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients[J].Transplantation 2000 ; 69 ( 7 ) : 1252-1260.

二级参考文献35

共引文献134

同被引文献25

  • 1高雪,蔡可丽,吴晓莉,杨雪丽,霍伟.雷帕霉素抑制兔眼后发性白内障的实验研究[J].山东大学学报(医学版),2006,44(6):634-637. 被引量:8
  • 2谭少健,梁皓,赵军,叶长华,胡启平.去整合素抑制体外培养的人眼晶状体上皮细胞生长的研究[J].广西医科大学学报,2006,23(3):348-351. 被引量:8
  • 3Kato K, Kurosaka D, Nagamoto T. Apoptotic cell death in rabbit lens after extraction [J]. Invest Ophthalmol Vis Sci 1997; 38 (11 ) :2322-2330.
  • 4Nishi O, Nishi K, Akaishi T, Shirasawa E. Detection of cell adhesion molecules in lens epithelial cells of human cataracts [ J ]. Invest Ophthalmol Vis Scg 1997;38(3) :579-585.
  • 5Fabio R, Zanetti A, Sironi M, Polentarutti N, Lanfrancone L, Dejana E, et al. Inhibition of anchorage dependent cell spreading triggers apoptosis in cultured human edothelial cell[ J]. Cell Biol 1994; 127 (3) :537-546.
  • 6Lee JW,Juliano RL. alphaSbetal integrin protects intestinal epithelial cell from apoptosis through a phosphatidyllnositol 3-kinase and protein kinase B-dependent pathway[ J ]. Mol Biol Cell 2000 ,11 (6) :1973-1987.
  • 7Grossmann J, Walther K, Artinger M, Kiessling S, Scholmerich J. Apoptotic signaling during initiation of detachment-induced apoptosis of primary human intestinal epithelial cells [ J ]. Cell Growth Differ 2001 ; 12 ( 3 ) : 147-155.
  • 8Strater J, Wedding U, Barth TF, Koretz K, Elsing C, Moller P. Rapid onset of apoptosis in vitro follows disruption of beta 1 integrin/matrix interactions in human colonic crypt cells[ J]. Gastroenterology 1996; 100 ( 6 ) : 1776-1784.
  • 9Adler M,Lazarus RA, Dennis MS, Wagner G. Solution structure of kistrin, a potent platelet aggregation inhibitor and GP Ⅱb-Ⅲa antagonist[ J]. Science 1991 ;253 ( 5018 ) :445-448.
  • 10Kim JT, Lee do H, Chung KH, Kang IC, Kim DS, Joo CK. Inhibitory effects of salmosin a disintegrin on posterior capsular opacification in vitro and in vivo [ J ]. Exp Eye Res 2002 ; 74 (5) :585-594.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部